featuring Patrick Kwan, Zanfina Ademi, Mark Howard, James McMahon and Tuncay Alan
Monash researchers make the case for investing in development and deployment of decentralised diagnostic devices, most importantly a highly-mobile and swift point-of-care (POC) COVID-19 nucleic acid test.
See full article (9 minute read)
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.